DBS Group (OTC: DBSDY), Singapore’s largest bank, reported a 10% rise in fourth-quarter net profit, reaching S$2.62 billion ($1.9 billion), aligning with analyst expectations. The bank also upgraded its 2025 net interest income (NII) outlook, expecting a slight increase over 2024 levels. Previously, it had projected NII to remain stable.
CEO Piyush Gupta highlighted that despite macroeconomic and geopolitical uncertainties, DBS’s decade-long digital transformation positions it for sustained strong returns. The bank’s net interest margin, a key profitability metric, improved to 2.15% from 2.13% a year earlier.
DBS announced a final dividend of 60 Singapore cents per share, up from 54 cents last year. Additionally, it introduced a capital return dividend of 15 Singapore cents per share per quarter for 2025, with similar payouts expected in the following two years.
As the first Singaporean lender to report earnings, DBS’s results underscore solid commercial and trading performance. However, analysts caution that Singapore banks may face challenges due to global economic uncertainty, including potential disruptions from U.S. trade policies. Rival United Overseas Bank (OTC: UOVEY) is set to release its earnings on Feb. 19.


Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears 



